Name: MarketsandMarkets Next-Gen Genomics and Proteomics Conference
Start: 2023-03-09
End: 2023-03-10
Location: ILEC Conference Centre & Ibis London Earls Court, London

WHAT TO EXPECT

Systemic Implementation of Functional Genomics, Organellar Proteomics for Biomedicine
Protein – DNA interaction Molecular and Cellular Mechanism, Applied and Translational Genomics in Systems Biology
Gene Expression and Molecular Mechanism in Immune Signaling, Flow Cytometry in Immune Phenotyping, Polygenic Risk Scores for Immuno Metabolic Markers
Predisposition of Biomarkers - NGS-RNA Sequencing, Single Cell Sequencing using Circulating Tumor Cells in Disease Diagnosis
Electrospray Mass Spectrometry based Biomarkers, Development of Multidimensional Liquid Chromatography, Spatial Profiling in Tumor Proteomics
Advances in Genome Wide Variant Data and Application of Omics in Protein – Protein interaction

Witness live action how Genomics and Proteomics is revolutionizing the future of Biomedical research
Quality insights and cohesiveness of key issues with respect to Genomics and Proteomics to be addressed
Discover the different avenues in application of Omics studies
Comprehend the current and future research avenues in drug discovery using Genomics and Proteomics
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson Ricardo Carreira, Associate Director - Proteomics, Immunocore	08:55 - 09:00
Molecular Insights in Developing Genomics and Proteomics Therapeutics
Human Genetics as an Enabler of RNAi Therapeutics Paul Nioi, Vice President, Discovery and Translational Research, Alnylam Pharmaceuticals	09:00 - 09:30
Challenges and Opportunities in National Precision Medicine Initiatives Alessandro Riccombeni, CEO and founder, Axia Medicine	09:30 - 10:00
Redefining Disease Research with 3D Genomics Ignacio Mazon Pelaez, Ph.D, Strategic Account Executive-EMEA, Arima Genomics	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 11:20
Large Scale Implementation of Population Wide Polygenic Risk Scores Manuel Corpas, Scientific Director, Cambridge Precision Medicine	11:20 - 11:50
The Complexities of Genomics – How my team have Overcome some of the Challenges Nik Matthews, Head of the Imperial BRC Genomics Facility, Imperial College London	11:50 - 12:20
MERFISH In Situ Single-Cell Transcriptomic Imaging in Formalin-Fixed Paraffin Embedded (FFPE) Tissues on the MERSCOPE Platform with Protein Co-Detection Justin Cooper, Regional Account Manager, UK and Benelux, Vizgen	12:20 - 12:50
Using Constrained Coding Region data to improve the identification of pathogenic de novo variants in the 100,000 Genomes Project Hywel Williams, Senior Lecturer in Bioinformatics, School of Medicine, Division of Cancer and Genetics, Cardiff University	12:50 - 13:20
Lunch and Poster Presentation \| One-to-One Networking	13:20 - 14:20
Identifying Targets for Immunotherapy with Mass Spectrometry-based Immunopeptidomics Ricardo Carreira, Associate Director - Proteomics, Immunocore	14:20 - 14:50
Spatial Visualization of Diverse RNA Biomarkers for Translational and Clinical Research Natalie Rowe, Spatial Biology Specialist, Bio-Techne	14:50 - 15:20
Influences of Rare Protein-Coding Genetic Variants on the Human Plasma Proteome in 50,829 UK Biobank Participants Eleanor Wheeler, Associate Principal Scientist, Genome Analytics, AstraZeneca	15:20 - 15:50
Evening Refreshments and Poster Presentation \| One-to-One Networking	15:50 - 16:30
Proteomics Strategies to Identify New Diagnostic and Therapeutic Targets Manuel Mayr, Professor for Cardiovascular Proteomics, King’s College London	16:30 - 17:00
Advancing Drug Discovery through Genetics and Genomics Nikolina Nakić, Senior Director, Head of V2G2F Computational Biology, GSK	17:00 - 17:30
Closing remarks by the Chairperson Ricardo Carreira, Associate Director - Proteomics, Immunocore	17:30 - 17:30
Drinks Reception and Networking	17:30 - 17:30
END OF DAY 1	17:30 - 17:30

Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson Amy Tibbo, Business Support Scientist EMEA, Bionano Genomics	08:55 - 09:00
Comprehensive Analysis of Quantitative Genomics
The Genomic Diversity of Human Brain Arijit Mukhopadhyay, Reader in Human Genetics, University of Salford	09:00 - 09:30
Next-Generation Cytogenomics with Optical Genome Mapping (OGM) Amy Tibbo, Business Support Scientist EMEA, Bionano Genomics	09:30 - 10:00
Long-Read Genomics for Assessing the Safety of Genome-Editing-based Therapeutics Saumyaa Saumyaa, Senior Research Scientist, AstraZeneca	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking	10:30 - 11:15
Streamlining Protein Extraction for Biomarker discovery and Beyond Silvia Wuertenberger, Product Manager BeatBox, PreOmics	11:15 - 11:45
Proteomics approaches to rationalise anticancer drug responses: towards next generation precision medicine Pedro Cutillas, Queen Mary University of London, Professor of Cell Signalling and Proteomics	11:45 - 12:15
Prioritising Genetic Variation in Immune Response to Infection through Functional Genomics Ping Zhang, Senior Postdoctoral Scientist, University of Oxford	12:15 - 12:45
Deciphering the Roles of Transposable Elements in Acute Myeloid Leukaemia through Functional Genomics Ozgen Deniz , Lecturer , Barts Cancer Institute/Queen Mary University of London	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking	13:15 - 14:15
Changing Research in Omics Data
Predicting genes associated with RNA methylation pathways using machine learning Georgia Tsagkogeorgia, Principal Scientist Bioinformatics, Storm Therapeutics	14:15 - 14:45
Using epigenetic editing to investigate Physiological Consequences of aberrant Epigenetic modifications in Primary Human Cells; Cancer Associated Reprogramming/ De-differentiation in Stem cells and pre-cancerous cells Gabriella Ficz, Senior Lecturer, Barts Cancer Institute/ Queen Mary University of London	14:45 - 15:15
Closing remarks by the Chairperson Amy Tibbo, Business Support Scientist EMEA, Bionano Genomics	15:15 - 15:15
End of Conference	15:15 - 15:15